Apremilast (Otezla): A New Oral Treatment for Adults With Psoriasis and Psoriatic Arthritis.

Article Details

Citation
Copy to clipboard

Zerilli T, Ocheretyaner E

Apremilast (Otezla): A New Oral Treatment for Adults With Psoriasis and Psoriatic Arthritis.

P T. 2015 Aug;40(8):495-500.

PubMed ID
26236137 [ View in PubMed
]
Abstract

Apremilast (Otezla): A new oral treatment for adults with psoriasis and psoriatic arthritis.

DrugBank Data that Cites this Article

Drugs
Drug Enzymes
DrugEnzymeKindOrganismPharmacological ActionActions
ApremilastCytochrome P450 1A2ProteinHumans
Unknown
Substrate
Details
ApremilastCytochrome P450 2A6ProteinHumans
Unknown
Substrate
Details
ApremilastCytochrome P450 3A4ProteinHumans
No
Substrate
Details